Display options
Cite
Beattie J, Parajuli S, Sanger M, et al. Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler. Infect Dis Clin Pract (Baltim Md). 2018;26(6):e80-e84doi: 10.1097/IPC.0000000000000654.
Beattie, J., Parajuli, S., Sanger, M., Lee, G., Pleninger, P., Crowley, G., Kwon, S., Murthy, V., Manko, J. A., Caplan, A., Dufort, E., Pastula, D. M., & Nolan, A. (2018). Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler. Infectious diseases in clinical practice (Baltimore, Md.), 26(6), e80-e84. https://doi.org/10.1097/IPC.0000000000000654
Beattie, Jason, et al. "Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler." Infectious diseases in clinical practice (Baltimore, Md.) vol. 26,6 (2018): e80-e84. doi: https://doi.org/10.1097/IPC.0000000000000654
Beattie J, Parajuli S, Sanger M, Lee G, Pleninger P, Crowley G, Kwon S, Murthy V, Manko JA, Caplan A, Dufort E, Pastula DM, Nolan A. Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler. Infect Dis Clin Pract (Baltim Md). 2018 Nov;26(6):e80-e84. doi: 10.1097/IPC.0000000000000654. PMID: 30923438; PMCID: PMC6433380.
Copy Download .nbib Format: NLM
Share it on

Infect Dis Clin Pract (Baltim Md). 2018 Nov;26(6):e80-e84. doi: 10.1097/IPC.0000000000000654.

Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler.

Infectious diseases in clinical practice (Baltimore, Md.)

Jason Beattie, Sunita Parajuli, Matthew Sanger, Gregory Lee, Perrin Pleninger, George Crowley, Sophia Kwon, Vivek Murthy, Jeffrey A Manko, Arthur Caplan, Elizabeth Dufort, Daniel M Pastula, Anna Nolan

Affiliations

  1. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, New York University, School of Medicine.
  2. Department of Medicine, Division of Infectious Diseases, New York University, School of Medicine.
  3. Department of Neurology, New York University, School of Medicine.
  4. Department of Emergency Medicine, New York University, School of Medicine.
  5. Division of Ethics, Department of Population Health, New York University, School of Medicine.
  6. New York State Department of Health, Division of Epidemiology, Albany, NY.
  7. Departments of Neurology, Medicine, and Epidemiology, University of Colorado Denver, Aurora, CO.
  8. Department of Environmental Medicine, New York University, School of Medicine, New York, NY.

PMID: 30923438 PMCID: PMC6433380 DOI: 10.1097/IPC.0000000000000654

Abstract

Zika virus (ZIKV) infection has been associated with Guillain-Barré Syndrome (GBS). Roughly 60% of people in countries such as the U.S. live in areas at risk for seasonal spread of ZIKV. ZIKV belongs to a class of diseases that is not typically seen in hospital settings across the U.S. and Europe. We describe the case presentation, management, and treatment of ZIKV infection complicated by GBS. A 64-year-old woman with recent travel to the Dominican Republic presented with rash followed by an acute, ascending polyneuropathy consistent with GBS. She was confirmed to have an acute ZIKV infection by detection of ZIKV nucleic acid by reverse transcription-polymerase chain reaction. She met Brighton Collaboration criteria level 1 evidence for GBS. She received two courses of intravenous immunoglobulin and slowly improved, though still had weakness at discharge. More research is needed to identify the pathophysiology behind ZIKV-associated GBS and its optimal treatment. Prevention is fundamental to limiting infection and spread of ZIKV.

Conflict of interest statement

Author Disclaimers: The authors declare that there is no conflict of interest regarding the publication of this paper.

References

  1. Trans R Soc Trop Med Hyg. 1956 Sep;50(5):442-8 - PubMed
  2. Trans R Soc Trop Med Hyg. 1964 Jul;58:335-8 - PubMed
  3. Bull World Health Organ. 1964;31:57-69 - PubMed
  4. Neurology. 2003 Sep 23;61(6):736-40 - PubMed
  5. Eur Spine J. 2005 Apr;14(3):250-60 - PubMed
  6. Arch Neurol. 2005 Aug;62(8):1194-8 - PubMed
  7. Lancet. 2005 Nov 5;366(9497):1653-66 - PubMed
  8. Neurology. 2007 Nov 27;69(22):2105-7 - PubMed
  9. Emerg Infect Dis. 2009 Mar;15(3):495-6 - PubMed
  10. Vaccine. 2011 Jan 10;29(3):599-612 - PubMed
  11. J Indian Med Assoc. 2011 Sep;109(9):675, 682 - PubMed
  12. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):711-8 - PubMed
  13. N Engl J Med. 2012 Jun 14;366(24):2294-304 - PubMed
  14. Neurol Clin. 2013 May;31(2):491-510 - PubMed
  15. Lancet Neurol. 2013 Sep;12(9):906-919 - PubMed
  16. Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72 - PubMed
  17. Emerg Infect Dis. 2015 Oct;21(10):1885-6 - PubMed
  18. N Engl J Med. 2016 Feb 18;374(7):601-4 - PubMed
  19. Lancet. 2016 Jan 23;387(10016):335-336 - PubMed
  20. BMJ. 2016 Feb 02;352:i657 - PubMed
  21. Lancet. 2016 Apr 2;387(10026):1481 - PubMed
  22. Lancet. 2016 Apr 9;387(10027):1531-1539 - PubMed
  23. N Engl J Med. 2016 Apr 21;374(16):1595-6 - PubMed
  24. Euro Surveill. 2016;21(9):30154 - PubMed
  25. N Engl J Med. 2016 May 19;374(20):1981-7 - PubMed
  26. Lancet. 2016 Apr 2;387(10026):1482 - PubMed
  27. Neurology. 2016 Jul 19;87(3):336-7 - PubMed
  28. MMWR Morb Mortal Wkly Rep. 2016 Jun 03;65(21):543-6 - PubMed
  29. Neurology. 2016 Oct 11;87(15):1623-1624 - PubMed
  30. MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):870-878 - PubMed
  31. MMWR Morb Mortal Wkly Rep. 2016 Sep 02;65(34):910-4 - PubMed
  32. J Clin Virol. 2016 Oct;83:63-5 - PubMed
  33. Emerg Infect Dis. 2016 Dec;22(12):2228-2230 - PubMed
  34. N Engl J Med. 2016 Nov 10;375(19):1907-1909 - PubMed
  35. N Engl J Med. 2016 Sep 29;375(13):1209-12 - PubMed
  36. Clin Transl Immunology. 2016 Dec 16;5(12):e117 - PubMed
  37. N Engl J Med. 2017 Apr 20;376(16):1591-1593 - PubMed
  38. N Engl J Med. 1995 Nov 23;333(21):1374-9 - PubMed
  39. Lancet. 1997 Jan 25;349(9047):225-30 - PubMed

Publication Types

Grant support